Canada markets open in 3 hours 18 minutes

Virios Therapeutics, Inc. (VIRI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4252-0.0058 (-1.35%)
At close: 04:00PM EDT
0.4430 +0.02 (+4.19%)
After hours: 07:41PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.19M
Enterprise Value 4.87M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.15
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.89

Trading Information

Stock Price History

Beta (5Y Monthly) 1.88
52-Week Change 3-51.15%
S&P500 52-Week Change 322.64%
52 Week High 32.4200
52 Week Low 30.2790
50-Day Moving Average 30.4094
200-Day Moving Average 30.7941

Share Statistics

Avg Vol (3 month) 3305.38k
Avg Vol (10 day) 3129.87k
Shares Outstanding 519.26M
Implied Shares Outstanding 619.26M
Float 816.68M
% Held by Insiders 19.71%
% Held by Institutions 18.09%
Shares Short (Apr 15, 2024) 4214.45k
Short Ratio (Apr 15, 2024) 40.36
Short % of Float (Apr 15, 2024) 41.18%
Short % of Shares Outstanding (Apr 15, 2024) 41.11%
Shares Short (prior month Mar 15, 2024) 4170.16k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-54.32%
Return on Equity (ttm)-95.14%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-5.3M
Diluted EPS (ttm)-0.2800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.32M
Total Cash Per Share (mrq)0.17
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.62
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-4.87M
Levered Free Cash Flow (ttm)-2.98M